Buy Lotrel (Amlodipine Besylate, Benazepril HCl) antihypertensive drug
Cheap qualitative Amlodipine with Benazepril 5 mg / 10 mg capsules online
HOW AND WHERE TO BUY LOTREL (AMLODIPINE, BENAZEPRIL) 5 MG / 10 MG CAPSULES OR TABLETS ONLINE:
LOTREL (AMLODIPINE, BENAZEPRIL): ADVERSE REACTIONS
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.
Lotrel (Amlodipine Besylate, Benazepril Hydrochloride) has been evaluated for safety in over 2,991 patients with hypertension; over 500 of these patients were treated for at
least 6 months, and over 400 were treated for more than 1 year.
In a pooled analysis of 5 placebo-controlled trials involving Lotrel doses up to 5 / 20, the reported side effects were generally mild and transient, and there was no relationship between side effects and age, sex, race, or duration of therapy. Discontinuation of therapy due to side effects was required in approximately 4% of patients treated with Lotrel (Amlodipine Besylate, Benazepril HCl) and in 3% of patients treated with placebo.
The most common reasons for discontinuation of therapy with Lotrel in these studies were cough and edema (including angioedema).
The peripheral edema associated with amlodipine use is dose-dependent. When benazepril is added to a regimen of amlodipine, the incidence of edema is substantially reduced.
The addition of benazepril to a regimen of amlodipine should not be expected to provide additional antihypertensive effect in African-Americans. However, all patient groups benefit from the reduction in amlodipine-induced edema.
The side effects considered possibly or probably related to study drug that occurred in these trials in more than 1% of patients treated with Lotrel are shown in the table below. Cough was the only adverse event with at least possible relationship to treatment that was more common on Lotrel (3.3%) than on placebo (0.2%).
Benazepril / Amlodipine; Benazepril; Amlodipine; Placebo
N=760 N=554 N=475 N=408
Cough 3.3 / 1.8 / 0.4 / 0.2
Headache 2.2 / 3.8 / 2.9 / 5.6
Dizziness 1.3 / 1.6 / 2.3 / 1.5
Edema 2.1 / 0.9 / 5.1 / 2.2
Edema refers to all edema, such as dependent edema, angioedema, facial edema.
The incidence of edema was greater in patients treated with amlodipine monotherapy (5.1%) than in patients treated with Lotrel (2.1%) or placebo (2.2%).
Other side effects considered possibly or probably related to study drug that occurred in U.S. placebo-controlled trials of patients treated with Lotrel or in postmarketing experience were the following:
Body as a Whole: fatigue, asthenia.
CNS: nervousness, insomnia, anxiety, tremor, decreased libido.
Dermatologic: hot flashes, flushing, rash, skin nodule, dermatitis.
Digestive: nausea, dry mouth, abdominal pain, diarrhea, constipation, dyspepsia, esophagitis.
Metabolic and Nutritional: hypokalemia.
Musculoskeletal: musculoskeletal pain, back pain, cramps, muscle cramps.
Urogenital: sexual problems such as impotence, polyuria.
Monotherapies of benazepril and amlodipine have been evaluated for safety in clinical trials in over 6,000 and 11,000 patients, respectively. The observed adverse reactions to the monotherapies in these trials were similar to those seen in trials of Amlodipine with Benazepril (Lotrel).
Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
In postmarketing experience with benazepril, there have been rare reports of Stevens-Johnson syndrome, hemolytic anemia, pancreatitis, pemphigus, and thrombocytopenia. Gingival hyperplasia, jaundice, tachycardia, and hepatic enzyme elevations (mostly consistent with cholestasis severe enough to require hospitalization) have been reported in association
with use of amlodipine. Other potentially important adverse experiences attributed to other ACE inhibitors and calcium channel blockers include: eosinophilic pneumonitis (ACE inhibitors) and gynecomastia (CCBs). Other infrequently reported events included chest pain, ventricular extrasystole, gout, neuritis, tinnitus, alopecia, upper respiratory tract
infection, palpitations and somnolence.
Lotrel (Amlodipine, Benazepril) related pharmaceutical drugs and medications
|Trade name of the drug
||Pharmaceutical forms and doses
|Benazepril Aurobindo - Benazepril Hydrochloride
||Tablets, Film-Coated; Oral; Benazepril Hydrochloride 10 mgTablets, Film-Coated; Oral; Benazepril Hydrochloride 20 mgTablets, Film-Coated; Oral; Benazepril Hydrochloride 40 mg
|Atorvastatiini - Atorvastatin Calcium
||N / A
||N / A
Buy Lotrel (Amlodipine, Benazepril) Online
Lotrel prescribing information
Copyright © Buy Lotrel (Amlodipine with Benazepril) Online